The co-administration of CpG-ODN influenced protective activity of influenza M2e vaccine (Q47895488)

6 February 2018

title

The co-administration of CpG-ODN influenced protective activity of influenza M2e vaccine (English)

1 reference

6 February 2018

0 references

Fan Wu

1

1 reference

6 February 2018

Xiao-Yi Yuan

series ordinal

2

1 reference

6 February 2018

Jing Li

series ordinal

3

1 reference

6 February 2018

Ying-Hua Chen

series ordinal

4

1 reference

6 February 2018

language of work or name

English

0 references

publication date

14 May 2009

1 reference

6 February 2018

published in

Vaccine

1 reference

6 February 2018

volume

27

1 reference

6 February 2018

issue

32

1 reference

6 February 2018

page(s)

4320-4324

1 reference

6 February 2018

Development of effective vaccines against pandemic influenza.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.075

A universal influenza A vaccine based on the extracellular domain of the M2 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.075

Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.075

Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.075

Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.075

Characterization of immunity induced by M2e of influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.075

Use of CpG oligodeoxynucleotides as immune adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.075

Protection capability of recombinant plasmid DNA vaccine containing VP2 gene of very virulent infectious bursal disease virus in chickens adjuvanted with CpG oligodeoxynucleotide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.075

DNA vaccination with VP2 gene of very virulent infectious bursal disease virus (vvIBDV) delivered by transgenic E. coli DH5alpha given orally confers protective immune responses in chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.075

Oligonucleotide containing CpG motifs enhances immune response to mucosally or systemically administered tetanus toxoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.075

CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.075

Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.075

Advances in vaccine adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.075

Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.075

Neonatal administration of IL-12 enhances the protective efficacy of antiviral vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.075

Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.075

Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.075

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2009.04.075

1 reference

6 February 2018

1 reference

6 February 2018